Literature DB >> 22518821

Among dual eligibles, identifying the highest-cost individuals could help in crafting more targeted and effective responses.

Teresa A Coughlin1, Timothy A Waidmann, Lokendra Phadera.   

Abstract

The nearly nine million people who receive Medicare and Medicaid benefits, known as dual eligibles, constitute one of the nation's most vulnerable and costly populations. Several initiatives authorized by the Affordable Care Act are intended to improve the health care delivered to dual eligibles and, at the same time, to achieve greater control of spending growth for the two government programs. We examined the 2007 costs and service use associated with dual eligibles. Although the population is indeed costly, we found nearly 40 percent of dual eligibles had lower average per capita spending than non-dual-eligible Medicare beneficiaries. In addition, we found that about 20 percent of dual eligibles accounted for more than 60 percent of combined Medicaid and Medicare spending on the dual-eligible population. But even among these high-cost dual eligibles, we found subgroups. For example, fewer than 1 percent of dual eligibles were in high-cost categories for both Medicare and Medicaid. These findings suggest that decision makers should tailor reform initiatives to account for subpopulations of dual eligibles, their costs, and their service use.

Entities:  

Mesh:

Year:  2012        PMID: 22518821     DOI: 10.1377/hlthaff.2011.0729

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  19 in total

1.  Recent Health Care Use and Medicaid Entry of Medicare Beneficiaries.

Authors:  Laura M Keohane; Amal N Trivedi; Vincent Mor
Journal:  Gerontologist       Date:  2017-10-01

2.  Forgotten patients: ACO attribution omits those with low service use and the dying.

Authors:  Mariétou H Ouayogodé; Ellen Meara; Chiang-Hua Chang; Stephanie R Raymond; Julie P W Bynum; Valerie A Lewis; Carrie H Colla
Journal:  Am J Manag Care       Date:  2018-07-01       Impact factor: 2.229

3.  Medicare-Medicaid eligible beneficiaries and potentially avoidable hospitalizations.

Authors:  Misha Segal; Eric Rollins; Kevin Hodges; Michelle Roozeboom
Journal:  Medicare Medicaid Res Rev       Date:  2014-01-15

4.  Effect of long-term care use on Medicare and Medicaid expenditures for dual eligible and non-dual eligible elderly beneficiaries.

Authors:  Robert L Kane; Andrea Wysocki; Shriram Parashuram; Tetyana Shippee; Terry Lum
Journal:  Medicare Medicaid Res Rev       Date:  2013-08-22

5.  Effects of Early Dual-Eligible Special Needs Plans on Health Expenditure.

Authors:  Yongkang Zhang; Mark L Diana
Journal:  Health Serv Res       Date:  2017-10-18       Impact factor: 3.402

6.  State variation in the characteristics of Medicare-Medicaid dual enrollees: Implications for risk adjustment.

Authors:  Eric T Roberts; Jennifer M Mellor; Melissa McInerney; Lindsay M Sabik
Journal:  Health Serv Res       Date:  2019-10-01       Impact factor: 3.402

7.  Risk adjusting for Medicaid participation in Medicare Advantage.

Authors:  Laura M Keohane; David G Stevenson; Lucas Stewart; Sunita Thapa; Salama Freed; Melinda B Buntin
Journal:  Am J Manag Care       Date:  2020-08-01       Impact factor: 2.229

8.  Spending differences associated with the Medicare Physician Group Practice Demonstration.

Authors:  Carrie H Colla; David E Wennberg; Ellen Meara; Jonathan S Skinner; Daniel Gottlieb; Valerie A Lewis; Christopher M Snyder; Elliott S Fisher
Journal:  JAMA       Date:  2012-09-12       Impact factor: 56.272

9.  High-Cost Dual Eligibles' Service Use Demonstrates The Need For Supportive And Palliative Models Of Care.

Authors:  Julie P W Bynum; Andrea Austin; Donald Carmichael; Ellen Meara
Journal:  Health Aff (Millwood)       Date:  2017-07-01       Impact factor: 6.301

10.  A Risk Scoring System for the Prediction of Functional Deterioration, Institutionalization, and Mortality Among Medicare Beneficiaries.

Authors:  Heather F McClintock; Jibby E Kurichi; Pui L Kwong; Dawei Xie; Margaret G Stineman; Hillary R Bogner
Journal:  Am J Phys Med Rehabil       Date:  2018-10       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.